← Eichor
Condition: Mucopolysaccharidosis Iv A Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Mucopolysaccharidosis Iv A

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cardiac Structure and Function in MPS
Phase N/A · 3 location(s) · Children's Hospital of Orange County · NCT07361536Registry of Patients Diagnosed With Lysosomal Storage Diseases
Phase N/A · 1 location(s) · University of California, San Francisco · NCT05619900Effects of Bisphosphonates on OI-Related Hearing Loss
Phase 4 · 1 location(s) · Hospital for Special Surgery, New York · NCT04152551Effect of Chronic Feeding of Inulin And Methylcellulose on Colonic Fermentation
NA · 2 location(s) · University of Nottingham · NCT06551961A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Ind
NA · 1 location(s) · Kiwi Health Inc · NCT07591584Non-invasive Functional Assessment and Pathogenesis of Morquio A
Phase N/A · 1 location(s) · Nemours Children's Clinic · NCT05284006PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
Phase 1 · 1 location(s) · University of California, San Francisco · NCT04532047A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms
NA · 1 location(s) · Supplement Formulators, Inc. · NCT07371975A Natural History Study in Children With a Type II Collagen Disorder With Short Stature
Phase N/A · 2 location(s) · Innoskel · NCT05408715Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients
NA · 1 location(s) · University Hospital, Montpellier · NCT05858606Longitudinal Study of Neurodegenerative Disorders
Phase N/A · 1 location(s) · University of Pittsburgh · NCT03333200Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
Phase 2 · 12 location(s) · QED Therapeutics, a BridgeBio company · NCT07169279
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.